Kaneko H, Kuroshima S, Kozutsumi R, Al Omari F, Hayano H, Nakajima K, et al. Zoledronate/Anti-VEGF Neutralizing Antibody Combination Administration Increases Osteal Macrophages in a Murine Model of MRONJ Stage 0-like Lesions. J Clin Med. 2023;12: pubmed publisher

Mashima T, Wakatsuki T, Kawata N, Jang M, Nagamori A, Yoshida H, et al. Neutralization of the induced VEGF-A potentiates the therapeutic effect of an anti-VEGFR2 antibody on gastric cancer in vivo. Sci Rep. 2021;11:15125 pubmed publisher

Huang J, Kelly C, Bakirtzi K, Villafuerte Gálvez J, Lyras D, Mileto S, et al. Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis. Nat Microbiol. 2019;4:269-279 pubmed publisher

Lu R, Kujawski M, Pan H, Shively J. Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. Cancer Res. 2012;72:2239-50 pubmed publisher

Kumar V, Scandella E, Danuser R, Onder L, Nitschké M, Fukui Y, et al. Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway. Blood. 2010;115:4725-33 pubmed publisher

Basu A, Contreras A, Datta D, Flynn E, Zeng L, Cohen H, et al. Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer. Cancer Res. 2008;68:5689-98 pubmed publisher